OMNY Health announced that it has partnered with the nation's leading community-based ophthalmology practices to launch a first-of-a-kind, real-world data ecosystem focused on driving...
The company, with its blend of advanced technology and network of trusted sellers, seems to only be gaining momentum. With a consistent and dramatic...
Amicrobe, Inc. develops synthetic biologics with physical and antimicrobial properties, called Amicidins. the Company announced the selection of lead clinical formulation for Amicidin-α PFC...
OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced the completion of a $35 million Series C funding...
